Takayasu's arteritis screening

Revision as of 17:24, 1 May 2018 by Ssharfaei (talk | contribs) (→‎Screening)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Takayasu's arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Takayasu's arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

Echocardiography and Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Takayasu's arteritis screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Takayasu's arteritis screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Takayasu's arteritis screening

on Takayasu's arteritis screening

Takayasu's arteritis screening in the news

Blogs onTakayasu's arteritis screening

Directions to Hospitals Treating Takayasu's arteritis

Risk calculators and risk factors for Takayasu's arteritis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farnaz Khalighinejad, MD [2]


Overview

According to the United States Preventive Services Task Force, screening for Takayasu's arteritis is not recommended.

Screening

According to the United States Preventive Services Task Force, screening for Takayasu's arteritis is not recommended.

References

Template:WH Template:WS